# Biotech Daily Digest â€” 2025-11-04

**56 items from 4 sources**

## Summary by Source

- Endpoints News: 12 items
- Fierce Biotech: 6 items
- Regeneron Press Releases: 1 item
- arXiv q-bio: 37 items


## Endpoints News

- **[Jennifer Doudna startup Azalea Therapeutics launches with $82M](https://endpoints.news/jennifer-doudna-startup-azalea-therapeutics-launches-with-82m/)**  
  _Tue, 04 Nov 2025 13:00:49 +0000_  
  Figuring out how to transport genetic medicines to the right parts of the body remains one of the great technical challenges constraining CRISPRâ€™s potential. Now, one of the inventors of a gene editing tool has ...

- **[Swiss biotech CDR-Life returns to Boehringer Ingelheim to partner on autoimmune T cell engager](https://endpoints.news/swiss-biotech-cdr-life-returns-to-boehringer-to-partner-on-autoimmune-t-cell-engager/)**  
  _Tue, 04 Nov 2025 13:00:32 +0000_  
  CDR-Life has inked a second licensing pact with Boehringer Ingelheim, as the Zurich-based startup will work with the German drug company in a ripe area of dealmaking.

 For 38 million Swiss francs (about $48 million) ...

- **[Blackstone to pay Merck $700M to fund development of antibody-drug conjugate](https://endpoints.news/blackstone-will-pay-merck-700m-to-fund-development-of-antibody-drug-conjugate/)**  
  _Tue, 04 Nov 2025 12:29:04 +0000_  
  Blackstone Life Sciences will give a major financial boost to Merck's development of an antibody-drug conjugate targeting TROP2, taking over some of the financial risk for an asset the drugmaker acquired through a 2022 partnership ...

- **[Pfizer trims pipeline, reports 7% revenue decline for Q3](https://endpoints.news/pfizer-reports-revenue-decline-boosts-earnings-guidance-and-trims-pipeline/)**  
  _Tue, 04 Nov 2025 12:07:42 +0000_  
  While Pfizer is embroiled in pharmaâ€™s most dramatic M&A battle in years, the company is also remaking its own pipeline, disclosing 11 program cuts during Thursdayâ€™s third-quarter earnings announcement.

 The cuts include ...

- **[South Korean biotech sets up California startup to advance ADCs](https://endpoints.news/south-korean-biotech-sets-up-california-startup-to-advance-adcs/)**  
  _Tue, 04 Nov 2025 12:00:25 +0000_  
  ABL Bio, a multi-partnered South Korean biotech, is backing a new Palo Alto, CA-based startup to carry forward two antibody-drug conjugates.

 NEOK Bio emerged on Tuesday with a $75 million Series A, with ABL Bio ...

- **[Post-Hoc Live: M&A, FDA, MFN and moreÂ  â€” with our cousins at the FT](https://endpoints.news/post-hoc-live-ma-fda-mfn-and-more-with-our-cousins-at-the-ft/)**  
  _Tue, 04 Nov 2025 12:00:13 +0000_  
  Itâ€™s been a heck of a week (and itâ€™s only Tuesday).

 Today on Post-Hoc Live at 11 a.m. ET, Iâ€™ll be joined by my colleague at the Financial Times, Global Pharmaceutical Editor Hannah Kuchler. Next ...

- **[Duchenne confirmatory trial fails, but Sarepta to ask FDA for full approval anyway](https://endpoints.news/duchenne-confirmatory-trial-fails-but-sarepta-to-ask-fda-for-full-approval-anyways/)**  
  _Tue, 04 Nov 2025 00:20:06 +0000_  
  Sarepta Therapeuticsâ€™ long-awaited confirmatory study of two of its exon-skipping therapies for forms of Duchenne muscular dystrophy failed to meet its primary endpoint, the company announced Monday.

 Despite the miss, the company plans to ask ...

- **[AbbVie gets early win in Oklahoma 340B fight, but faces setback in Colorado](https://endpoints.news/abbvie-gets-early-win-in-oklahoma-340b-fight-but-faces-setback-in-colorado/)**  
  _Mon, 03 Nov 2025 20:18:49 +0000_  
  Two federal district courts have reached opposite conclusions in cases challenging states' authority to regulate how drugmakers distribute 340B discounts.

 An Oklahoma federal judge on Friday preliminarily blocked the state from forcing AbbVie, Novartis and ...

- **[Lilly earmarks $3B for new European obesity pill factory](https://endpoints.news/lilly-earmarks-3b-for-new-european-obesity-pill-factory/)**  
  _Mon, 03 Nov 2025 17:58:52 +0000_  
  Eli Lilly plans to build another facility to make its oral GLP-1 drug orforglipron. The $3 billion site will be located in Katwijk, the Netherlands.

 In addition to orforglipron, the new site will make other ...

- **[UK regulators look to speed up how rare disease therapies reach the market](https://endpoints.news/uk-regulators-look-to-speed-up-how-rare-disease-therapies-reach-the-market/)**  
  _Mon, 03 Nov 2025 17:24:47 +0000_  
  The UK's medicines regulatory agency said it is working to "overhaul" its framework for approving rare disease therapies.

 The Medicines and Healthcare products Regulatory Agency (MHRA) said on Sunday it is ...

- **[Metsera calls Pfizer threats 'nonsense' as rift widens between companies](https://endpoints.news/metsera-calls-pfizer-threats-nonsense-as-rift-widens-between-companies/)**  
  _Mon, 03 Nov 2025 16:46:46 +0000_  
  Pfizer and Novo Nordisk's battle over obesity biotech Metsera is getting ugly.

 On Monday, Metsera asked the Delaware Court of Chancery to deny Pfizer's request for a hearing to determine whether to temporarily block Metsera ...

- **[TScan to cut a third of its staff; Iovance advances Amtagvi in lung cancer](https://endpoints.news/tscan-to-cut-a-third-of-its-staff-iovance-advances-amtagvi-in-lung-cancer/)**  
  _Mon, 03 Nov 2025 15:43:34 +0000_  
  Plus, news about Krystal Biotech, Serina Therapeutics, Rein Therapeutics, Knight Therapeutics, Kyverna Therapeutics, Roche, Alvotech, Savara and MindMed:

 ðŸ’¼ TScan Therapeutics to lay off 66 workers: The biotech said it reached ...


## Fierce Biotech

- **[<a href="https://www.fiercebiotech.com/biotech/merck-writes-tale-2-checks-bagging-700m-blackstone-while-spending-150m-regain-asset" hreflang="en">Merck writes tale of 2 checks, bagging $700M from Blackstone and spending $150M to regain asset</a>](https://www.fiercebiotech.com/biotech/merck-writes-tale-2-checks-bagging-700m-blackstone-while-spending-150m-regain-asset)**  
  _Nov 4, 2025 8:40am_  
  Merck & Co. began Tuesday with back-to-back deals, revealing separate agreements to pay $150 million upfront for full control of an early-phase asset and pocket $700 million to support an expansive pivotal oncology push.

- **[<a href="https://www.fiercebiotech.com/biotech/new-vivo-cell-therapy-biotech-blossoms-crispr-pioneer-doudnas-laboratory-82m" hreflang="en">New in vivo cell therapy biotech blossoms from CRISPR pioneer Jennifer Doudna's lab with $82M</a>](https://www.fiercebiotech.com/biotech/new-vivo-cell-therapy-biotech-blossoms-crispr-pioneer-doudnas-laboratory-82m)**  
  _Nov 3, 2025 2:18pm_  
  A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed with $82 million in funding and a dual-vector approach that the company hopes can enable permanent genome editing with aâ€¦

- **[<a href="https://www.fiercebiotech.com/pharma/sarepta-pushes-full-approval-duchenne-drugs-despite-missed-confirmatory-trial-goal" hreflang="en">Sarepta pushes for full approval of Duchenne drugs despite missed confirmatory trial goal</a>](https://www.fiercebiotech.com/pharma/sarepta-pushes-full-approval-duchenne-drugs-despite-missed-confirmatory-trial-goal)**  
  _Nov 3, 2025 9:14pm_  
  A long-running confirmatory trial of two of Sarepta Therapeuticsâ€™ Duchenne muscular dystrophy drugs has missed its main goal. The development comes just as the company and the FDA work to formally limit the indication of another Sarepta product, the gene therapy Elevidys.

- **[<a href="https://www.fiercebiotech.com/biotech/abl-spinout-neok-exits-stealth-75m-take-bispecific-adcs-clinic" hreflang="en">ABL spinout Neok exits stealth with $75M to take bispecific ADCs into the clinic</a>](https://www.fiercebiotech.com/biotech/abl-spinout-neok-exits-stealth-75m-take-bispecific-adcs-clinic)**  
  _Oct 31, 2025 10:09am_  
  Neok Bio has exited stealth with $75 million to take a pair of bispecific antibody-drug conjugates sourced from ABL Bio into the clinic.

- **[<a href="https://www.fiercebiotech.com/pharma/cder-chief-tidmarsh-resigns-deleted-linkedin-post-blasting-lupkynis-prompts-aurinia-lawsuit" hreflang="en">CDER chief George Tidmarsh resigns as deleted LinkedIn post prompts Aurinia lawsuit, FDA probe</a>](https://www.fiercebiotech.com/pharma/cder-chief-tidmarsh-resigns-deleted-linkedin-post-blasting-lupkynis-prompts-aurinia-lawsuit)**  
  _Nov 3, 2025 9:42am_  
  High-ranking FDA official George Tidmarsh, M.D., Ph.D., has tendered his resignation after an unconventional LinkedIn diatribe landed the senior drug regulator at the center of a lawsuit and an internal probe.

- **[<a href="https://www.fiercebiotech.com/biotech/tempero-calls-time-alcohol-use-disorder-while-mulling-options-according-partner" hreflang="en">Tempero calls time on alcohol use disorder while mulling options, according to partner</a>](https://www.fiercebiotech.com/biotech/tempero-calls-time-alcohol-use-disorder-while-mulling-options-according-partner)**  
  _Nov 3, 2025 9:08am_  
  Tempero Bio has hit the brakes on a phase 2-stage alcohol use disorder program while the biotech considers its options, according to the programâ€™s partner.


## Regeneron Press Releases

- **[Regeneron Announces Investor Conference Presentations](https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-investor-conference-presentations-22)**  
  _Mon, 03 Nov 2025 16:05:00 -0500_  
  TARRYTOWN, N.Y. , Nov. 03, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ:Â  REGN ) will webcast management participation as follows: Jefferies London Healthcare Conference at 3:30 p.m. GMT ( 10:30 a.m. ET ) on Monday, November 17, 2025 7 th Annual Wolfe Research Healthcare


## arXiv q-bio

- **[Using machine learning methods to predict cognitive age from psychophysiological tests](https://arxiv.org/abs/2511.00013)**  
  _Tue, 04 Nov 2025 00:00:00 -0500_  
  arXiv:2511.00013v1 Announce Type: new 
Abstract: This study introduces a novel method for predicting cognitive age using psychophysiological tests. To determine cognitive age, subjects were asked to complete a series of psychological tests measuring various cognitive functions, including reaction time and cognitive coâ€¦

- **[AI-derived layer-specific OCT biomarkers for classification of geographic atrophy](https://arxiv.org/abs/2511.00057)**  
  _Tue, 04 Nov 2025 00:00:00 -0500_  
  arXiv:2511.00057v1 Announce Type: new 
Abstract: Geographic atrophy (GA) is a key biomarker of dry age-related macular degeneration (AMD) traditionally identified through color fundus photography. Hyper-transmission defects (hyperTDs), a feature highly correlated with GA, have recently gained prominence in optical cohâ€¦

- **[Pharmacovigilance Analysis of Drug-Induced Rhabdomyolysis Based on the FDA Adverse Event Reporting System (FAERS)](https://arxiv.org/abs/2511.00093)**  
  _Tue, 04 Nov 2025 00:00:00 -0500_  
  arXiv:2511.00093v1 Announce Type: new 
Abstract: This study aimed to systematically identify and quantify risks for drug-induced rhabdomyolysis (DIR) using real-world data and to propose an evidence-based risk mitigation framework. We conducted a retrospective pharmacovigilance study using the FDA Adverse Event Reportâ€¦

- **[GeneFlow: Translation of Single-cell Gene Expression to Histopathological Images via Rectified Flow](https://arxiv.org/abs/2511.00119)**  
  _Tue, 04 Nov 2025 00:00:00 -0500_  
  arXiv:2511.00119v1 Announce Type: new 
Abstract: Spatial transcriptomics (ST) technologies can be used to align transcriptomes with histopathological morphology, presenting exciting new opportunities for biomolecular discovery. Using ST data, we construct a novel framework, GeneFlow, to map transcriptomics onto pairedâ€¦

- **[AmpliconHunter2: a SIMD-Accelerated In-Silico PCR Engine](https://arxiv.org/abs/2511.00170)**  
  _Tue, 04 Nov 2025 00:00:00 -0500_  
  arXiv:2511.00170v1 Announce Type: new 
Abstract: Summary: We present AmpliconHunter2 (AHv2), a highly scalable in silico PCR engine written in C that can handle degenerate primers and uses a highly accurate melting temperature model. AHv2 implements a bit-mask IUPAC matcher with AVX2 SIMD acceleration, supports user-sâ€¦

- **[SCUDDO: An unsupervised clustering algorithm for single-cell Hi-C maps using diagonal diffusion operators](https://arxiv.org/abs/2511.00278)**  
  _Tue, 04 Nov 2025 00:00:00 -0500_  
  arXiv:2511.00278v1 Announce Type: new 
Abstract: Motivation: Advances in high-throughput chromatin conformation capture have provided insight into the three- dimensional structure and organization of chromatin. While bulk Hi-C experiments capture spatio-temporally averaged chromatin interactions across millions of celâ€¦

- **[Theoretical morphology of a cichlid according to the approach of Systemic Morphometry](https://arxiv.org/abs/2511.00310)**  
  _Tue, 04 Nov 2025 00:00:00 -0500_  
  arXiv:2511.00310v1 Announce Type: new 
Abstract: We analyzed the body structure of the Blackstripe Cichlid Vieja fenestrata (G\"unther, 1860), a species with highly phenotypic variability, by the Systemics Morphometrics Methodology, previously proposed by one of the authors. From this perspective and considering the pâ€¦

- **[Mathematical modeling of tumor-immune interactions: methods, applications, and future perspectives](https://arxiv.org/abs/2511.00507)**  
  _Tue, 04 Nov 2025 00:00:00 -0500_  
  arXiv:2511.00507v1 Announce Type: new 
Abstract: Mathematical oncology is a rapidly evolving interdisciplinary field that uses mathematical models to enhance our understanding of cancer dynamics, including tumor growth, metastasis, and treatment response. Tumor-immune interactions play a crucial role in cancer biologyâ€¦

- **[The Future Orchid Diversity of Great Britain and Ireland using an SDM Approach](https://arxiv.org/abs/2511.01122)**  
  _Tue, 04 Nov 2025 00:00:00 -0500_  
  arXiv:2511.01122v1 Announce Type: new 
Abstract: In this paper we use Species Distribution Models (SDMs) to forecast the future diversity and distribution of orchids in Great Britain and Ireland under scenarios of climate and land-use change. The study analyzes occurrence data for native orchid taxa in the BSBI databaâ€¦

- **[STELLAR-koff: A Transfer Learning Model for Protein-Ligand Dissociation Rate Constant Prediction Based on Interaction Landscape](https://arxiv.org/abs/2511.01171)**  
  _Tue, 04 Nov 2025 00:00:00 -0500_  
  arXiv:2511.01171v1 Announce Type: new 
Abstract: The key to successful drug design lies in the correct comprehension of protein-ligand interactions. Within the current knowledge paragm, these interactions can be described from both thermodynamic and kinetic perspectives. In recent years, many deep learning models haveâ€¦

- **[Fast, memory-efficient genomic interval tokenizers for modern machine learning](https://arxiv.org/abs/2511.01555)**  
  _Tue, 04 Nov 2025 00:00:00 -0500_  
  arXiv:2511.01555v1 Announce Type: new 
Abstract: Introduction: Epigenomic datasets from high-throughput sequencing experiments are commonly summarized as genomic intervals. As the volume of this data grows, so does interest in analyzing it through deep learning. However, the heterogeneity of genomic interval data, wheâ€¦

- **[Temperature reshapes epigenomic diversity in Arabidopsis thaliana - JSD and Methylator reveal RdDM-CMT2 plasticity](https://arxiv.org/abs/2511.01834)**  
  _Tue, 04 Nov 2025 00:00:00 -0500_  
  arXiv:2511.01834v1 Announce Type: new 
Abstract: DNA methylation can be associated with phenotypic plasticity, yet how temperature shapes DNA methylation diversity in natural populations is unclear. Analyzing whole-genome bisulfite sequencing from 1075 Arabidopsis thaliana accessions grown at 10{\deg}C, 16{\deg}C, andâ€¦

- **[Incentives for self-isolation based on incidence rather than prevalence could help to flatten the curve: a modelling study](https://arxiv.org/abs/2511.00138)**  
  _Tue, 04 Nov 2025 00:00:00 -0500_  
  arXiv:2511.00138v1 Announce Type: cross 
Abstract: In recent years, numerous advances have been made in understanding how epidemic dynamics is affected by changes in individual behaviours. We propose an SIS-based compartmental model to tackle the simultaneous and coupled evolution of an outbreak and of the adoption byâ€¦

- **[Diffusion Models at the Drug Discovery Frontier: A Review on Generating Small Molecules versus Therapeutic Peptides](https://arxiv.org/abs/2511.00209)**  
  _Tue, 04 Nov 2025 00:00:00 -0500_  
  arXiv:2511.00209v1 Announce Type: cross 
Abstract: Diffusion models have emerged as a leading framework in generative modeling, showing significant potential to accelerate and transform the traditionally slow and costly process of drug discovery. This review provides a systematic comparison of their application in desâ€¦

- **[Thermal Stress Disrupts Symbiotic Fluid Dynamics in Bobtail Squid](https://arxiv.org/abs/2511.00326)**  
  _Tue, 04 Nov 2025 00:00:00 -0500_  
  arXiv:2511.00326v1 Announce Type: cross 
Abstract: The impact of thermal stress on beneficial symbiosis, in the face of rapid climate change, remains poorly understood. We investigate this using the model system, Euprymna scolopes, the Hawaiian Bobtail Squid, and its bioluminescent symbiont, Vibrio fischeri, which enaâ€¦

- **[Sparse and nonparametric estimation of equations governing dynamical systems with applications to biology](https://arxiv.org/abs/2511.00579)**  
  _Tue, 04 Nov 2025 00:00:00 -0500_  
  arXiv:2511.00579v1 Announce Type: cross 
Abstract: Data-driven discovery of model equations is a powerful approach for understanding the behavior of dynamical systems in many scientific fields. In particular, the ability to learn mathematical models from data would benefit systems biology, where the complex nature ofâ€¦

- **[High-Power Dual-Channel Field Chamber for High-Frequency Magnetic Neuromodulation](https://arxiv.org/abs/2511.00745)**  
  _Tue, 04 Nov 2025 00:00:00 -0500_  
  arXiv:2511.00745v1 Announce Type: cross 
Abstract: Several novel methods, including magnetogenetics and magnetoelectric stimulation, use high frequency alternating magnetic fields to precisely manipulate neural activity. To quantify the behavioral effects of such interventions in a freely moving mouse, we developed aâ€¦

- **[Detecting active L\'evy particles using differential dynamic microscopy](https://arxiv.org/abs/2511.00775)**  
  _Tue, 04 Nov 2025 00:00:00 -0500_  
  arXiv:2511.00775v1 Announce Type: cross 
Abstract: Detecting L\'evy flights of cells has been a challenging problem in experiments. The challenge lies in accessing data in spatiotemporal scales across orders of magnitude, which is necessary for reliably extracting a power-law scaling. Differential dynamic microscopy hâ€¦

- **[Deciphering Scientific Collaboration in Biomedical LLM Research: Dynamics, Institutional Participation, and Resource Disparities](https://arxiv.org/abs/2511.00818)**  
  _Tue, 04 Nov 2025 00:00:00 -0500_  
  arXiv:2511.00818v1 Announce Type: cross 
Abstract: Large language models (LLMs) are increasingly transforming biomedical discovery and clinical innovation, yet their impact extends far beyond algorithmic revolution-LLMs are restructuring how scientific collaboration occurs, who participates, and how resources shape inâ€¦

- **[Design, Assessment, and Application of Machine Learning Potential Energy Surfaces](https://arxiv.org/abs/2511.00951)**  
  _Tue, 04 Nov 2025 00:00:00 -0500_  
  arXiv:2511.00951v1 Announce Type: cross 
Abstract: Potential Energy Surfaces (PESs) are an indispensable tool to investigate, characterise and understand chemical and biological systems in the gas and condensed phases. Advances in Machine Learning (ML) methodologies have led to the development of Machine Learned Potenâ€¦

- **[Modeling Microenvironment Trajectories on Spatial Transcriptomics with NicheFlow](https://arxiv.org/abs/2511.00977)**  
  _Tue, 04 Nov 2025 00:00:00 -0500_  
  arXiv:2511.00977v1 Announce Type: cross 
Abstract: Understanding the evolution of cellular microenvironments in spatiotemporal data is essential for deciphering tissue development and disease progression. While experimental techniques like spatial transcriptomics now enable high-resolution mapping of tissue organizatiâ€¦

- **[Identification of Capture Phases in Nanopore Protein Sequencing Data Using a Deep Learning Model](https://arxiv.org/abs/2511.01277)**  
  _Tue, 04 Nov 2025 00:00:00 -0500_  
  arXiv:2511.01277v1 Announce Type: cross 
Abstract: Nanopore protein sequencing produces long, noisy ionic current traces in which key molecular phases, such as protein capture and translocation, are embedded. Capture phases mark the successful entry of a protein into the pore and serve as both a checkpoint and a signaâ€¦

- **[Geometric Modeling of Hippocampal Tau Deposition: A Surface-Based Framework for Covariate Analysis and Off-Target Contamination Detection](https://arxiv.org/abs/2511.01732)**  
  _Tue, 04 Nov 2025 00:00:00 -0500_  
  arXiv:2511.01732v1 Announce Type: cross 
Abstract: We introduce a framework combining geometric modeling with disease progression analysis to investigate tau deposition in Alzheimer's disease (AD) using positron emission tomography (PET) data. Focusing on the hippocampus, we construct a principal surface that capturesâ€¦

- **[Low-fat diets and testosterone in men: Systematic review and meta-analysis of intervention studies](https://arxiv.org/abs/2204.00007)**  
  _Tue, 04 Nov 2025 00:00:00 -0500_  
  arXiv:2204.00007v2 Announce Type: replace 
Abstract: Background: Higher endogenous testosterone levels are associated with reduced chronic disease risk and mortality. Since the mid-20th century, there have been significant changes in dietary patterns, and men's testosterone levels have declined in western countries. Câ€¦

- **[Augmenting learning in neuro-embodied systems through neurobiological first principles](https://arxiv.org/abs/2407.04525)**  
  _Tue, 04 Nov 2025 00:00:00 -0500_  
  arXiv:2407.04525v5 Announce Type: replace 
Abstract: Recent progress in artificial intelligence (AI) has been driven by insights from physics and neuroscience, particularly through the development of artificial neural networks (ANNs) capable of complex cognitive tasks such as vision and language processing. Despite thâ€¦

- **[Comparative in-silico study of aqueous humour flow and drug release from intraocular implants for glaucoma treatment](https://arxiv.org/abs/2410.01082)**  
  _Tue, 04 Nov 2025 00:00:00 -0500_  
  arXiv:2410.01082v3 Announce Type: replace 
Abstract: Drug-releasing implants are gaining momentum in the treatment of glaucoma. Implants present however several limitations. Among these limitations, there is the inability to provide an even distribution of the drug in the trabecular meshwork. CFD simulations were usedâ€¦

- **[IUPAC-Induced Computational Approaches for Identifying Boosters of Small Biomolecule Functionality: A Case Study of Human Tyrosyl-DNA Phosphodiesterase 1 (TDP1) Inhibitors](https://arxiv.org/abs/2503.05591)**  
  _Tue, 04 Nov 2025 00:00:00 -0500_  
  arXiv:2503.05591v3 Announce Type: replace 
Abstract: This paper introduces several proof-of-concept (PoC) computational methods intended to offer biochemical researchers straightforward, time- and cost-effective strategies to accelerate their work. While Machine Learning (ML) models were developed, the study's centralâ€¦

- **[How causal perspectives can inform neuroscience data analysis](https://arxiv.org/abs/2503.10710)**  
  _Tue, 04 Nov 2025 00:00:00 -0500_  
  arXiv:2503.10710v3 Announce Type: replace 
Abstract: Over the past two decades, considerable strides have been made in advancing neuroscientific techniques, yet challenges remain in attributing causality to observed associations. This review addresses a fundamental issue in observational neuroscience studies and advocâ€¦

- **[How spatial patterns can lead to less resilient ecosystems](https://arxiv.org/abs/2505.08671)**  
  _Tue, 04 Nov 2025 00:00:00 -0500_  
  arXiv:2505.08671v2 Announce Type: replace 
Abstract: Several theoretical models predict that spatial patterning increases ecosystem resilience. However, these predictions rely on simplifying assumptions, such as assuming isotropic and infinitely large ecosystems, and empirical evidence directly linking spatial patternâ€¦

- **[Practical indistinguishability in a gene regulatory network inference problem, a case study](https://arxiv.org/abs/2508.21006)**  
  _Tue, 04 Nov 2025 00:00:00 -0500_  
  arXiv:2508.21006v2 Announce Type: replace 
Abstract: Determining mechanistic models of gene regulation, especially underlying phenotypic variation, is a central goal of both mathematical biology and modern evolutionary biology. However, several challenges, involving both common characteristics of experimental data andâ€¦

- **[Low Total Fertility in Simple Economic Systems](https://arxiv.org/abs/2406.13816)**  
  _Tue, 04 Nov 2025 00:00:00 -0500_  
  arXiv:2406.13816v2 Announce Type: replace-cross 
Abstract: Low total fertility rates throughout the world have lead to concerns about economic growth, military security, international political power, environment impacts, and quality of life. Overall total fertility rates of today's societies are complex emergent funcâ€¦

- **[AI-Guided Molecular Simulations in VR: Exploring Strategies for Imitation Learning in Hyperdimensional Molecular Systems](https://arxiv.org/abs/2409.07189)**  
  _Tue, 04 Nov 2025 00:00:00 -0500_  
  arXiv:2409.07189v2 Announce Type: replace-cross 
Abstract: Molecular dynamics (MD) simulations are a crucial computational tool for researchers to understand and engineer molecular structure and function in areas such as drug discovery, protein engineering, and material design. Despite their utility, MD simulations arâ€¦

- **[From Epilepsy Seizures Classification to Detection: A Deep Learning-based Approach for Raw EEG Signals](https://arxiv.org/abs/2410.03385)**  
  _Tue, 04 Nov 2025 00:00:00 -0500_  
  arXiv:2410.03385v2 Announce Type: replace-cross 
Abstract: Epilepsy represents the most prevalent neurological disease in the world. One-third of people suffering from mesial temporal lobe epilepsy (MTLE) exhibit drug resistance, urging the need to develop new treatments. A key part in anti-seizure medication (ASM) deâ€¦

- **[Temporal Feature Learning in Weakly Labelled Bioacoustic Cetacean Datasets via a Variational Autoencoder and Temporal Convolutional Network: An Interdisciplinary Approach](https://arxiv.org/abs/2410.17006)**  
  _Tue, 04 Nov 2025 00:00:00 -0500_  
  arXiv:2410.17006v3 Announce Type: replace-cross 
Abstract: Bioacoustics data from Passive acoustic monitoring (PAM) poses a unique set of challenges for classification, particularly the limited availability of complete and reliable labels in datasets due to annotation uncertainty, biological complexity due the heterogâ€¦

- **[Vision-Language Model-Based Semantic-Guided Imaging Biomarker for Lung Nodule Malignancy Prediction](https://arxiv.org/abs/2504.21344)**  
  _Tue, 04 Nov 2025 00:00:00 -0500_  
  arXiv:2504.21344v3 Announce Type: replace-cross 
Abstract: Machine learning models have utilized semantic features, deep features, or both to assess lung nodule malignancy. However, their reliance on manual annotation during inference, limited interpretability, and sensitivity to imaging variations hinder their applicâ€¦

- **[Asymptotic Robustness in Biochemical Systems](https://arxiv.org/abs/2505.21900)**  
  _Tue, 04 Nov 2025 00:00:00 -0500_  
  arXiv:2505.21900v3 Announce Type: replace-cross 
Abstract: Living systems maintain stable internal states despite environmental fluctuations. Absolute concentration robustness (ACR) is a striking homeostatic phenomenon in which the steady-state concentration of a species remains invariant despite changes in total suppâ€¦

- **[Mantis: A Simulation-Grounded Foundation Model for Disease Forecasting](https://arxiv.org/abs/2508.12260)**  
  _Tue, 04 Nov 2025 00:00:00 -0500_  
  arXiv:2508.12260v3 Announce Type: replace-cross 
Abstract: Infectious disease forecasting in novel outbreaks or low-resource settings is hampered by the need for disease-specific data, bespoke training, and expert tuning. We introduce Mantis, a foundation model trained entirely on mechanistic simulations, which enableâ€¦
